To explore whether the aforementioned alterations in bone microarchitecture in the cKD mice, with or without EPO treatment, may also be related to changes in the RANKL/OPG axis, we analyzed the expression of RANKL and OPG in the whole bone (proximal tibia)24 at the end of the treatment period (2 weeks). Here, EPO is linked to chronic kidney disease.